Tags

Type your tag names separated by a space and hit enter

Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement From the American College of Lifestyle Medicine.
Am J Lifestyle Med. 2020 Jul-Aug; 14(4):406-419.AJ

Abstract

Objectives. The present review represents the position of the American College of Lifestyle Medicine on type 2 diabetes (T2D) and remission treatment. Background. Research now reveals that sufficiently intensive lifestyle interventions can produce remission of T2D with similar success to bariatric surgery, but with substantially fewer untoward side effects. Methods. A literature review was conducted to examine lifestyle modifications targeting T2D remission, with most studies using a combination of blood glucose markers and treatment history. Results. There were notable differences in the dosing intensity of lifestyle interventions between therapeutic interventions and subtherapeutic interventions. Studies with therapeutic dosing typically used very low energy diets (600-1100 kcal/day) with a weighted mean remission rate of 49.4%, while studies with subtherapeutic dosing typically used more moderate caloric restrictions (reducing energy intake by 500-600 kcal/day) and the weighted mean remission rate was 6.9%. Conclusions. Remission should be the clinical goal in T2D treatment, using properly dosed intensive lifestyle interventions as a primary component of medical care for T2D patients.

Authors+Show Affiliations

Loma Linda University Health, Loma Linda, California (JK). American College of Lifestyle Medicine, Chesterfield, Missouri (JK, MK). University of New England, Portland, Maine (MK). Erlanger Health System, Chattanooga, Tennessee (GS).Loma Linda University Health, Loma Linda, California (JK). American College of Lifestyle Medicine, Chesterfield, Missouri (JK, MK). University of New England, Portland, Maine (MK). Erlanger Health System, Chattanooga, Tennessee (GS).Loma Linda University Health, Loma Linda, California (JK). American College of Lifestyle Medicine, Chesterfield, Missouri (JK, MK). University of New England, Portland, Maine (MK). Erlanger Health System, Chattanooga, Tennessee (GS).

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33281521

Citation

Kelly, John, et al. "Type 2 Diabetes Remission and Lifestyle Medicine: a Position Statement From the American College of Lifestyle Medicine." American Journal of Lifestyle Medicine, vol. 14, no. 4, 2020, pp. 406-419.
Kelly J, Karlsen M, Steinke G. Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement From the American College of Lifestyle Medicine. Am J Lifestyle Med. 2020;14(4):406-419.
Kelly, J., Karlsen, M., & Steinke, G. (2020). Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement From the American College of Lifestyle Medicine. American Journal of Lifestyle Medicine, 14(4), 406-419. https://doi.org/10.1177/1559827620930962
Kelly J, Karlsen M, Steinke G. Type 2 Diabetes Remission and Lifestyle Medicine: a Position Statement From the American College of Lifestyle Medicine. Am J Lifestyle Med. 2020 Jul-Aug;14(4):406-419. PubMed PMID: 33281521.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement From the American College of Lifestyle Medicine. AU - Kelly,John, AU - Karlsen,Micaela, AU - Steinke,Gregory, Y1 - 2020/06/08/ PY - 2020/05/01/received PY - 2020/05/08/revised PY - 2020/05/12/accepted PY - 2020/12/7/entrez PY - 2020/12/8/pubmed PY - 2020/12/8/medline KW - lifestyle medicine KW - plant-based diet KW - remission KW - reversal KW - type 2 diabetes SP - 406 EP - 419 JF - American journal of lifestyle medicine JO - Am J Lifestyle Med VL - 14 IS - 4 N2 - Objectives. The present review represents the position of the American College of Lifestyle Medicine on type 2 diabetes (T2D) and remission treatment. Background. Research now reveals that sufficiently intensive lifestyle interventions can produce remission of T2D with similar success to bariatric surgery, but with substantially fewer untoward side effects. Methods. A literature review was conducted to examine lifestyle modifications targeting T2D remission, with most studies using a combination of blood glucose markers and treatment history. Results. There were notable differences in the dosing intensity of lifestyle interventions between therapeutic interventions and subtherapeutic interventions. Studies with therapeutic dosing typically used very low energy diets (600-1100 kcal/day) with a weighted mean remission rate of 49.4%, while studies with subtherapeutic dosing typically used more moderate caloric restrictions (reducing energy intake by 500-600 kcal/day) and the weighted mean remission rate was 6.9%. Conclusions. Remission should be the clinical goal in T2D treatment, using properly dosed intensive lifestyle interventions as a primary component of medical care for T2D patients. SN - 1559-8284 UR - https://www.unboundmedicine.com/medline/citation/33281521/full_citation DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.